|
Santa Cruz Biotechnology
mouse anti bub1 Mouse Anti Bub1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bub1/BUB1+Antibody/pm42869150-230-101-103 Average 93 stars, based on 1 article reviews
mouse anti bub1 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
MedChemExpress
sirnas targeting bub1 Sirnas Targeting Bub1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bub1/BAY-1816032/pm42014906-101-7-17 Average 95 stars, based on 1 article reviews
sirnas targeting bub1 - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Addgene inc
pdonr223 bub1 Pdonr223 Bub1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bub1/pDONR223-BUB1+(Plasmid+%2323612)/pmc12887411-249-39-40 Average 94 stars, based on 1 article reviews
pdonr223 bub1 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
bub1 sirna ![]() Bub1 Sirna, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bub1/BUB1+Rabbit+pAb/pmc12976074-224-18-14 Average 94 stars, based on 1 article reviews
bub1 sirna - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Rockland Immunochemicals
human bub1 antibody ![]() Human Bub1 Antibody, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bub1/BUB1+ANTIBODY/pmc12871464-130-17-39 Average 94 stars, based on 1 article reviews
human bub1 antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Rockland Immunochemicals
sheep polyclonal ![]() Sheep Polyclonal, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bub1/BUB1+ANTIBODY/pmc12871464-130-14-39 Average 94 stars, based on 1 article reviews
sheep polyclonal - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Rockland Immunochemicals
sb1 3 ![]() Sb1 3, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bub1/BUB1+ANTIBODY/pmc12871464-130-19-39 Average 94 stars, based on 1 article reviews
sb1 3 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
anti bub1 ![]() Anti Bub1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bub1/pmc12881636-185-18-22 Average 86 stars, based on 1 article reviews
anti bub1 - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
Journal: Scientific Reports
Article Title: BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer
doi: 10.1038/s41598-026-38997-4
Figure Lengend Snippet: Expression profile of BUB1 in lung cancer. ( A ) BUB1 mRNA expression across various cancer types from the GEPIA database, with LUAD and LUSC highlighted in blue. ( B , C ) BUB1 mRNA expression in non-paired ( B ) and paired tumor tissues ( C ) in TCGA-LUAD dataset.( D , E ) BUB1 mRNA expression in non-paired ( D ) and paired tumor tissues ( E ) in TCGA-LUSC dataset. ( F , G ) BUB1 mRNA expression in non-paired tumor tissues in the GSE31210 dataset ( G ) and paired tumor tissues in the GSE75037 dataset ( G ) for LUAD. ( H , I ) BUB1 mRNA expression in non-paired tumor tissues in the GSE33532 ( H ) and paired tumor tissues in the GSE134381 dataset ( G ) for LUSC. * P < 0.05, *** P < 0.001.
Article Snippet: For IL-17 pathway inhibition studies, cells were co-treated with 1:200 diluted neutrilizing IL-17C antibody (
Techniques: Expressing
Journal: Scientific Reports
Article Title: BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer
doi: 10.1038/s41598-026-38997-4
Figure Lengend Snippet: Diagnostic and prognostic value of BUB1 in lung cancer. ( A ) RT-qPCR validation of BUB1 mRNA expression in paired clinical specimens ( n = 30, tumor vs. adjacent normal tissues) from the First Affiliated Hospital of Dalian Medical University. Data normalized to GAPDH and presented as mean ± SD. ( B ) Representative immunohistochemical staining (400× magnification, scale bar = 50 μm) and quantitative H-score analysis of BUB1 protein levels in clinical FFPE tumor tissues acquired from the First Affiliated Hospital of Dalian Medical University, with statistical analysis shown. ( C ) ROC curve analysis of BUB1’s diagnostic performance in clinical lung cancer tissues based on RT-qPCR data, with optimal cutoff determined by Youden’s index. ( D – F ) ROC curve analysis for BUB1’s diagnostic value in LUAD using public in silico datasets of TCGA-LUAD ( D ), GSE31210 ( E ) and GSE75037 ( F ). ( G – I ) ROC curve analysis for BUB1’s detection value in LUSC based on public datasets of TCGA-LUSC ( G ), GSE33532 ( H ) and GSE134381 ( I ). ( J , K ) Kaplan-Meier survival curves showing BUB1’s prognostic value for overall survival (OS) and relapse free survival (RFS) in LUAD ( GSE13213 and GSE31210 ) (J) and LUSC ( GSE17710 ) (K) patients from the PrognoScan database. ( L , N ) uniCox regression analysis of BUB1’s prognostic significance in LUAD ( L ) and LUSC ( N ). (M , O ) multiCox regression analysis of BUB1’s independent prognostic value for LUAD ( M ) and LUSC ( O ) after controlling for age, gender, stage and TN stages. * P < 0.05, ** P < 0.01, *** P < 0.001.
Article Snippet: For IL-17 pathway inhibition studies, cells were co-treated with 1:200 diluted neutrilizing IL-17C antibody (
Techniques: Diagnostic Assay, Quantitative RT-PCR, Biomarker Discovery, Expressing, Immunohistochemical staining, Staining, In Silico
Journal: Scientific Reports
Article Title: BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer
doi: 10.1038/s41598-026-38997-4
Figure Lengend Snippet: BUB1 knockdown suppressed stem-like features in lung cancer cells. ( A , B ) RT-qPCR validation of BUB1 knockdown efficiency in A549 ( A ) and H226 ( B ) cells 48 h post-transfection with three independent BUB1 siRNAs. ( C ) Representative Western blot showing BUB1 protein levels 48 h post-siRNA transfection, with β-actin as loading control. The presented blots were representative of at least three independent experiments. ( D ) Sphere formation assay demonstrating reduced tumor sphere number and diameter following BUB1 knockdown (Scale bar =100 μm). ( E , F ) RT-qPCR analysis of stemness markers (EpCAM, MSI1, BMI1, Sox2) in A549 ( E ) and H226 ( F ) cells after BUB1 knockdown. ( G ) Western blot analysis of stemness markers 48 h post-BUB1 knockdown, with β-actin as loading control. The presented blots were representative of at least three independent experiments. * P < 0.05, ** P < 0.01, *** P < 0.001.
Article Snippet: For IL-17 pathway inhibition studies, cells were co-treated with 1:200 diluted neutrilizing IL-17C antibody (
Techniques: Knockdown, Quantitative RT-PCR, Biomarker Discovery, Transfection, Western Blot, Control, Tube Formation Assay
Journal: Scientific Reports
Article Title: BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer
doi: 10.1038/s41598-026-38997-4
Figure Lengend Snippet: Association between BUB1 expression and immune infiltration in lung cancer by using TCGA datasets. ( A , B ) Comparison of immune cell infiltration levels between low- and high-BUB1 groups in TCGA-LUAD ( A ) and TCGA-LUSC ( B ) cohorts. ( C , D ) Pearson correlation analysis between BUB1 expression and relative abundance of 22 immune cell types in TCGA-LUAD ( C ) and TCGA-LUSC ( D ) datasets. * P < 0.05, ** P < 0.01, *** P < 0.001.
Article Snippet: For IL-17 pathway inhibition studies, cells were co-treated with 1:200 diluted neutrilizing IL-17C antibody (
Techniques: Expressing, Comparison
Journal: Scientific Reports
Article Title: BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer
doi: 10.1038/s41598-026-38997-4
Figure Lengend Snippet: BUB1 suppressed stem-like properties in lung cancer cells through IL-17 signaling pathway. ( A , B ) RT-qPCR analysis of IL-17C and IL-17RE expression in A549 ( A ) and H226 ( B ) cells 48 h post-BUB1 knockdown. ( C ) Representative Western blot showing IL-17C and IL-17RE protein levels 48 h post-BUB1 knockdown, with β-actin as loading control. The presented blots were representative of at least three independent experiments. ( D ) Sphere formation assay demonstrating alterations in stem-like features following BUB1 knockdown or combined stimulation with anti-IL17C. ( E ) Western blot analysis of stemness markers following BUB1 knockdown or combined anti-IL17C blockade. The presented blots were representative of at least three independent experiments. ** P < 0.01, *** P < 0.001.
Article Snippet: For IL-17 pathway inhibition studies, cells were co-treated with 1:200 diluted neutrilizing IL-17C antibody (
Techniques: Quantitative RT-PCR, Expressing, Knockdown, Western Blot, Control, Tube Formation Assay
Journal: Scientific Reports
Article Title: BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer
doi: 10.1038/s41598-026-38997-4
Figure Lengend Snippet: Drug screening identified BUB1-targeting compounds. ( A – C ) Three-dimensional molecular structures of candidate drugs predicted to bind to BUB1 in lung cancer. ( D – F ) Molecular docking analysis showing binding patterns between BUB1 and quercetin ( D ), cryptolepine ( E ) and etoposide ( F ).
Article Snippet: For IL-17 pathway inhibition studies, cells were co-treated with 1:200 diluted neutrilizing IL-17C antibody (
Techniques: Drug discovery, Binding Assay